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Fatty acid profiles of muscle, liver, 
heart and kidney of Australian 
prime lambs fed different 
polyunsaturated fatty acids 
enriched pellets in a feedlot system
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Peter David Nichols1,5 & Aduli Enoch Othniel Malau-Aduli  1
We investigated the effect of various dietary polyunsaturated fatty acid (PUFA) sources on the fatty 
acid profiles of muscle, liver, heart and kidney of Australian prime lambs. Seventy-two White Suffolk x 
Corriedale first-cross lambs weaned at 6 months of age were randomly allocated to the following six 
treatments: (1) Control: Lucerne hay only; wheat-based pellets infused with 50 ml/kg dry matter (DM) 
of oil from (2) rice bran (RBO); (3) canola (CO); (4) rumen-protected (RPO), (5) flaxseed (FSO) and (6) 
safflower (SO) sources in a completely randomized experimental design. Lambs in CO, FSO, SO and 
RPO treatments achieved contents of eicosapentaenoic acid (EPA, 22:5n-3) plus docosahexaenoic acid 
(DHA, 22:6n-3) in the longissimus dorsi muscle ranging from 31.1 to 57.1 mg/135 g, over and above the 
30 mg per standard serve (135 g) threshold for “source” claim under the Australian guidelines. There 
was no difference in n-3 LC-PUFA contents in longissimus dorsi muscle of lambs fed dietary oils of plant 
origin. The highest 18:3n-3 (ALA) contents achieved with FSO diet in the muscle, liver and heart were 
45.6, 128.1 and 51.3 mg/100 g, respectively. Liver and kidney contained high contents of n-3 LC-PUFA 
(ranging from 306.7 to 598.2 mg/100 g and 134.0 to 300.4 mg/100 g, respectively), with all values 
readily exceeding the ‘good source’ status (60 mg per serve under Australian guidelines). The liver 
and kidney of PUFA fed lambs can be labelled as ‘good source’ of n-3 LC-PUFA based on EPA and DHA 
contents stipulated by the Food Standards of Australia and New Zealand guidelines. Therefore, if lamb 
consumers consider eating the liver and kidney as their dietary protein sources, they can adequately 
obtain the associated health benefits of n-3 LC-PUFA.
Accumulating scientific evidence demonstrates the important role that omega-3 long-chain (>C20) polyunsatu-
rated fatty acids (n-3 LC-PUFA) play in conditions such as cardiovascular disease, certain cancers and other dis-
eases1,2. Chen et al.3 suggested that both dietary and circulating LC-PUFA were inversely associated with all-cause 
mortality. In another study, Stark et al.4 found that most of the countries and regions of the world having very 
low to low range of blood n-3 LC-PUFA were associated with an increased risk of chronic diseases. Therefore, 
the consumption of adequate n-3 LC-PUFA is crucial to maintaining a healthy body and for the prevention of 
chronic diseases. However, humans like all other mammals, cannot synthesise n-3 LC-PUFA because they lack 
the necessary Δ12 and Δ15-desaturase enzymes. Therefore, these health-benefitting fatty acids must be supplied 
in the diet5. Humans can obtain n-3 LC-PUFA or their C18 PUFA precursors from various sources including 
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aquatic (fish, crustaceans, and mollusks), farm livestock products (meat, egg, and milk), oilseeds, fruits, herbs, 
cyanobacteria and microorganisms (bacteria, fungi, microalgae, and diatoms)6. Ruminant meat research has 
drawn considerable attention because ruminant meat contains some bioactive lipids (including n-3 LC-PUFA) 
and the fatty acid profiles of ruminant meat can be enhanced through dietary supplementation7,8. In this regard, 
the manipulation of fatty acid profiles in sheep meat via dietary n-3 LC-PUFA supplementation has yielded 
some promising results. Flakemore et al.9 reported that supplementation of degummed crude canola oil to lambs 
improved n-3 LC-PUFA contents in meat. Supplementing prime lambs with 5% flaxseed or canola oil pellets 
increased n-3 LC-PUFA in the liver, heart, kidney and longissimus thoracis et lumborum muscle tissue10,11. Boles 
et al.12 found that supplementation of safflower oil at up to 6% of sheep diet on as-fed basis, increased levels of 
PUFA and conjugated linoleic acids (especially the cis-9, trans-11 isomer) in the lean tissue. However, the studies 
described above emphasised the need to find new n-3 LC-PUFA feed sources and associated optimal supplemen-
tation levels. There are only a handful of published comparative studies into different dietary oil sources and their 
ability to elevate the level of n-3 LC-PUFA in lamb, especially under feedlot finishing systems. Feeding lambs in 
an intensive finishing system, such as a feedlot, has rapidly become a specialised component of the prime lamb 
industry with the number of lambs being grain finished steadily increasing. This increase in intensive feeding can 
be mainly attributed to the export demand for a consistent supply of lambs that meet market specifications. This 
is particularly so when quality pasture feed is unavailable or during drought conditions. Therefore, we hypothe-
sised herein that the fatty acid profiles of the longissimus dorsi muscle, liver, kidney and heart of Australian prime 
lambs would differ in response to supplementation with various dietary PUFA sources under a typical intensive, 
in-door feedlot management system. It was intended that this study would provide outcomes that can be used 
as guidelines for lamb producers for a better utilisation of available dietary n-3 LC-PUFA sources for enhancing 
lamb nutritional quality and beneficial human health outcomes.
Results
Fatty acid profiles in basal and supplementary feed. Fatty acid composition (as % total fatty acids) of 
both basal and supplementary feeds are presented in Table 1. Lucerne hay contained high proportions of PUFA 
and n-3 PUFA (48.7 and 28.2%, respectively). The major fatty acids in lucerne hay were 18:2n-6 (LA) and 18:3n-3 
(ALA), with relatively high levels of 19.0 and 27.5%, respectively. Similarly, flaxseed oil infused pellets (FSO) 
contained relatively high levels of PUFA and n-3 PUFA (62.2 and 20.7%, respectively) and the major fatty acids in 
FSO were LA (41.0%), ALA (20.5%) and 18:1n-9 (18.8%). The remaining treatments were rich in PUFA and n-6 
PUFA with relatively high levels ranging from 39 to 59 (%) and 34 to 57(%), respectively, in which the major fatty 
acids were LA and 18:1n-9. The highest n-6 PUFA level was found in safflower oil infused pellets (SO) (mainly 
LA: 56.5%). The rumen protected oil infused pellets (RPO) had the highest proportions of n-3 LC-PUFA com-
prising 4.8% eicosapentaenoic acid (EPA, 20:5n-3), docosapentaenoic acid (DPA, 22:5n-3) and docosahexaenoic 
acid (DHA, 22:6n-3).
Fatty acid profiles in the longissimus dorsi muscle. Fatty acid contents (mg/100 g) of the longissimus 
dorsi muscle tissue is depicted in Table 2. There was no difference among treatments in total fatty acids (FA), 
saturated fatty acids (SFA) and monounsaturated fatty acids (MUFA). The PUFA, n-3 LC-PUFA, n-3 PUFA and 
18:1n-7t of supplemented treatments were significantly higher than that of control. The RPO treatment had the 
highest contents of n-3 LC-PUFA (66 mg/100 g); mainly EPA, DPA and DHA. The highest mean of ALA was 
found in the FSO treatment (45.6 mg/100 g) and the lowest value was in the control. All supplemented treatments, 
except for RPO, had significantly higher values of LA than that of control. The SO treatment contained the highest 
contents of n-6 PUFA and n-6/n-3 ratios of all treatments varied from 1.8 to 3.5.
Fatty acid profiles in edible organs. Fatty acid profiles in the liver. Table 3 shows the fatty acid contents 
(mg/100 g) of liver tissue. The means of all fatty acid components in the liver were markedly higher than those in 
the muscle and significant differences were evident in both saturated and unsaturated FA. The CO treatment had 
the highest total FA (3775.0 mg/100 g) and MUFA (1018.0 mg/100 g) contents. The lowest SFA and 18:0 contents 
were found in the RPO group (1086.0 mg/100 g and 595.5 mg/100 g, respectively). Contents of n-6 PUFA and 
LA in all supplemented treatments, except for RPO, were significantly higher than in the control. RPO had the 
highest n-3 PUFA and n-3 LC-PUFA which mainly consisted of EPA, DPA and DHA. The ratio of n-6/n-3 in all 
treatments ranged from 0.6 to 1.9. The highest value of ALA was found in the FSO treatment (128.1 mg/100 g).
Fatty acid profiles in the heart. Table 4 depicts fatty acid contents (mg/100 g) of the heart. There was no dif-
ference in total FA, SFA and MUFA; similar to the same trend observed in the longissimus dorsi muscle. PUFA 
and 18:1n-7t in all supplemented treatments were significantly higher than in the control treatment. The con-
trol had the lowest contents of n-6 PUFA and LA. The RPO treatment had the highest n-3 LC-PUFA and n-3 
PUFA, whilst the lowest contents of these FA were in the control treatment. FSO had the highest ALA content 
(51.3 mg/100 g). SO and rice bran infused pellets (RBO) treatments had the highest n-6/n-3 ratio and RPO had 
the lowest. Generally, the n-6/n-3 ration in all treatments ranged from 2.7 to 6.6.
Fatty acid profiles in the kidney. Table 5 shows the fatty acid contents (mg/100 g) in the kidney. SFA contents 
did not differ among treatments. All supplemented treatments had significantly higher PUFA and LA contents 
than the control. RPO treatment had the highest n-3 LC-PUFA and n-3 PUFA contents. The highest total FA, n-6 
PUFA and LA contents were in the SO treatment (2305.0; 752.6 and 375.8 mg/100 g, respectively). The observed 
trend of n-3 LC-PUFA content was similar to the pattern observed in the liver where only FSO treatment had 
greater n-3 LC-PUFA content than the control. The range in n-6/n-3 ratio in all treatments was from 1.3 to 4.0 in 
which the SO treatment had the highest ratio.
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Discussion
Past studies had used raw oil or oilseeds as supplements in ruminant feeding trials. In order to minimise oxidative 
rancidity, improve stability and shelf life of both feeds and meat products, we chose to use oil-infused pellets as an 
innovative means of delivering n-3 LC-PUFA to lambs. Besides, available information on the effect of oil-infused 
pellets on the fatty acid profile of lamb is scanty in the published literature. Furthermore, the use of oil-infused 
pellets is less bulky than raw oil or oilseeds, hence our strategy minimises transportation and storage issues in 
commercial lamb feed production. The fatty acid profile of lucerne hay was similar to that reported by Nguyen 
et al.10. Many past studies had reported that flaxseed oil contained a high concentration of ALA13–16. Our study 
showed that FSO had the highest concentration of ALA among the supplemented treatments. The high concen-
tration of LA in SO observed in this study was consistent with other previous studies12,17. The RPO treatment 
contained high concentrations of EPA, DPA and DHA because of its fish oil content.
In the longissimus dorsi muscle, the higher contents of n-3 LC-PUFA in the supplemented treatments can be 
explained by the higher levels of by-pass lipids and protection from excessive lipolysis and extensive biohydro-
genation in the rumen18,19 as observed in previous studies9,10,20. On the other hand, it would seem that the levels 
and extent of biohydrogenation and conversion of stearate (18:0) into Oleate (18:1n-9) were similar, hence the 
Fatty acid Lucerne hay RBO CO FSO SO RPO
14:0 0.4 0.1 0.1 0.1 0.2 2.4
15:0 0.5 0.1 0.1 0.1 0.1 0.4
16:1n-9c 0.0 0.0 0.0 0.0 0.0 0.0
16:1n-7c 0.5 0.2 0.3 0.3 0.2 4.0
16:0 26.6 17.4 12.4 11.0 14.0 19.4
17:0 0.7 0.1 0.1 0.1 0.1 0.2
18:2n-6 LA 19.0 41.1 33.7 41.0 56.5 35.7
18:3n-3 ALA 27.5 2.3 4.8 20.5 1.7 2.7
18:1n-9 2.7 31.8 41.8 18.8 20.3 20.9
18:1n-7c 1.0 1.1 2.5 1.8 1.5 1.9
18:1n-7t 0.1 0.0 0.0 0.0 0.0 0.0
18:0 5.5 2.3 1.1 3.4 2.3 2.9
20:4n-6 ARA 0.2 0.0 0.0 0.0 0.0 0.2
20:5n-3 EPA 0.2 0.1 0.1 0.1 0.1 2.5
20:3n-6 0.4 0.2 0.1 0.3 0.5 0.4
20:4n-3 0.5 0.0 0.0 0.0 0.0 0.1
20:2n-6 0.3 0.1 0.1 0.1 0.1 0.1
20:0 1.6 0.6 0.6 0.4 0.5 0.4
22:5n-6 DPA-6 0.0 0.0 0.0 0.0 0.0 0.2
22:6n-3 DHA 0.0 0.0 0.0 0.0 0.0 1.6
22:5n-3 DPA-3 0.0 0.0 0.0 0.0 0.0 0.5
22:0 2.0 0.5 0.3 0.3 0.2 0.4
23:0 1.0 0.1 0.1 0.1 0.1 0.1
24:0 2.3 0.6 0.4 0.2 0.3 0.4
∑SFA 40.9 21.9 15.1 16.0 17.9 26.7
∑MUFA 9.7 34.0 45.7 21.8 22.9 28.3
∑PUFA 48.7 43.9 39.0 62.2 59.0 44.6
∑n-3 LC-PUFA 0.7 0.1 0.1 0.1 0.1 4.8
∑n-3 PUFA 28.2 2.4 4.9 20.7 1.7 7.4
∑n-6 PUFA 20.2 41.4 34.0 41.4 57.0 37.1
∑other FA 0.8 0.2 0.2 0.1 0.2 0.4
n-6/n-3 0.7 17.3 6.9 2.0 33.5 5.0
Table 1. Fatty acid composition (% total fatty acids) of basal and supplementary feeds. RBO, CO, RPO, FSO 
and SO were wheat-based pellets infused with 50 ml/kg DM of oil from rice bran, canola, rumen-protected, 
flaxseed and safflower sources, respectively; LA, linoleic acid; ALA, α-linolenic acid; EPA, eicosapentaenoic 
acid; DHA, docosahexaenoic acid; DPA, docosapentaenoic acid; ΣSFA, total saturated fatty acids; ΣMUFA, 
total monounsaturated fatty acids; and total polyunsaturated fatty acids (ΣPUFA); ∑SFA is the sum of 14:0, 
15:0, 16:0, 17:0, 18:0, 20:0, 21:0, 22:0, 23:0, 24:0; ∑MUFA is the sum of 14:1, 16:1n-13t, 16:1n-9, 16:1n-7, 16:1n-
7t, 16:1n-5c, 17:1n-8 + a17:0, 18:1n-9, 18:1n-7t, 18:1n-5, 18:1n-7, 18:1a, 18:1b, 18:1c, 19:1a, 19:1b, 20:1n-11, 
20:1n-9, 20:1n-7, 20:1n-5, 22:1n-9, 22:1n-11, 24:1n-9; ∑PUFA is the sum of 18:4n-3, 18:3n-6, 18:2n-6, 18:3n-3, 
20:3, 20:4n-3, 20:4n-6, 20:5n-3, 20:3n-6, 20:2n-6, 22:6n-3, 22:5n-3, 22:5n-6, 22:4n-6; ∑n-3 LC-PUFA is the sum 
of 20:5n-3, 20:4n-3, 22:6n-3, 22:5n-3; ∑n-3 PUFA is the sum of 18:3n-3, 18:4n-3, 20:4n-3, 20:5n-3, 22:6n-3, 
22:5n-3; ∑n-6 PUFA is the sum of 18:2n-6, 18:3n-6, 20:4n-6, 20:3n-6, 20:2n-6, 22:5n-6, 22:4n-6; ∑other FA is 
the sum of other individual FA present at <0.1% except ARA, DHA, EPA, and DPA.
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observed result where no difference was found in the 18:1n-9 content of the longissimus dorsi muscle between the 
supplemented and control treatments. This observation could also be indicative of similar delta-nine desaturase 
enzyme activities among treatment groups since it is the primary enzyme responsible for the conversion of stea-
rate to oleate in the biochemical pathway of in vivo lipid synthesis. One of the biohydrogenation intermediates of 
ALA and LA is 18:1n-7t21. The increased contents of ALA with flaxseed supplementation has also been reported 
in a previous study by Wachira et al.22 who reported that supplementation with flaxseed doubled the proportion 
(x100) of 18:3n-3 in the longissimus dorsi muscle from 1·4 to 3·1. Demirel et al.23 reported that feeding protected 
linseed resulted in 3.0-fold higher concentration of ALA in lamb muscles compared with Megalac (calcium soap 
of palm fatty acid distillate). The observed trend in our current study where the ALA content in the longissimus 
dorsi muscle of lambs in the FSO treatment was 1.9 times that of the control but similar EPA and DHA contents, 
could be due to the low elongase enzyme activity for the elongation of C18 to ≥C20 FA and subsequent desat-
uration of ALA into more potent n-3 LC-PUFA, and the capacity of muscle lipids to incorporate ALA into n-3 
LC-PUFA18.
In contrast, our finding that the RPO treatment had double EPA and triple DHA contents in longissimus dorsi 
muscle tissue in comparison with the control was in line with the results of Wachira et al.22 who reported that 
feeding fish oil increased the muscle proportion (x100) of EPA from 0·7 to 2·3 and DHA from 0·3 to 0·8. The 
greatest n-6 to n-3 ratio in SO treatment could be explained by high n-6 PUFA contents of safflower oil (57%) as 
shown in Table 1. According to Pannier, et al.24, a standard serve was 135 g of meat. Food Standards of Australia 
and New Zealand (FSANZ) regulate that a given food can be claimed as a ‘source’ of omega-3 fatty acids if the 
EPA + DHA contents of that food is greater than 30 mg per serve25. Lambs in the CO, FSO, SO and RPO treat-
ments had EPA + DHA content in the longissimus dorsi muscle exceeding the 30 mg per serve cut-off point for 
“source” claim under the FSANZ guidelines25 (as depicted in Fig. 1) and the n-6/n-3 ratio within the desirable 
Fatty acid Control RBO CO FSO SO RPO SEM P
14:0 24.1ab 34.6a 30.8ab 23.5ab 26.3ab 18.4b 4.81 0.047
15:0 4.6 5.9 4.9 3.5 4.2 3.5 0.77 0.259
16:1n-9c 3.1ab 4.0a 4.0a 2.6ab 3.1ab 2.4b 0.49 0.041
16:1n-7c 16.6 23.1 21.0 16.8 18.8 16.3 2.64 0.380
16:0 375.7 498.8 484.9 386.2 460.7 342.0 55.69 0.266
17:0 20.6 25.1 20.3 16.8 21.0 17.2 3.04 0.444
18:2n-6 LA 87.0c 158.5ab 140.0b 148.7b 196.8a 122.9bc 14.58 0.000
18:3n-3 ALA 23.9c 31.2bc 35.8b 45.6a 29.5bc 25.6c 2.95 0.000
18:1n-9 601.6 794.6 776.2 558.3 720.9 538.6 92.86 0.227
18:1n-7c 23.8b 36.6a 40.0a 31.1ab 36.1a 31.6ab 3.73 0.009
18:1n-7t 22.1b 50.3a 47.6a 50.4a 48.4a 42.2a 6.68 0.041
18:0 323.5 386.4 387.3 299.6 382.5 247.5 47.89 0.236
20:4n-6 ARA 27.9b 36.1ab 33.7ab 30.1b 45.2a 29.1b 4.45 0.046
20:5n-3 EPA 12.6c 16.0bc 18.1bc 19.8b 18.1bc 28.9a 2.02 0.000
20:3n-6 5.9ab 3.9b 5.6ab 5.3ab 6.7a 6.9a 0.74 0.048
20:4n-3 1.9bc 2.8ab 1.2bc 1.1bc 1.0c 4.2a 0.55 0.002
20:2n-6 1.4 1.6 1.7 1.4 2.2 2.3 0.30 0.168
20:0 2.4 3.1 3.0 2.2 2.9 2.2 0.39 0.383
22:5n-6 DPA-6 0.6ab 0.7a 0.5ab 0.3b 0.6ab 0.9a 0.13 0.042
22:6n-3 DHA 3.7b 4.3b 4.9b 5.4b 5.4b 13.3a 0.95 <0.0001
22:5n-3 DPA-3 10.1b 15.2ab 16.8a 14.4ab 18.0a 19.6a 1.97 0.033
22:0 1.2 1.3 1.2 1.1 1.2 0.9 0.17 0.605
23:0 1.9 1.5 1.4 1.3 1.5 1.3 0.23 0.462
24:0 1.9 1.8 1.6 1.3 1.7 1.8 0.22 0.534
Total FA 1748.0 2297.0 2241.0 1821.0 2218.0 1658.0 239.60 0.247
∑SFA 755.9 958.4 935.5 735.5 902.0 634.9 110.76 0.259
∑MUFA 717.0 966.8 947.5 713.3 883.2 677.1 109.81 0.254
∑PUFA 183.4b 279.2a 266.1a 279.7a 332.9a 260.8a 25.55 0.012
∑n-3 LC-PUFA 28.4c 38.3b 41.0b 40.7b 42.5b 66.0a 4.51 <0.0001
∑n-3 PUFA 52.2d 69.6c 76.7abc 86.9ab 72.7bc 91.6a 6.55 0.003
∑n-6 PUFA 124.8c 204.2ab 183.9bc 188.1b 254.9a 164.3bc 19.71 0.003
∑other FA 91.7 92.6 91.9 92.1 100.1 84.9 8.75 0.908
n-6/n-3 2.4c 3.0b 2.4c 2.2cd 3.5a 1.8d 0.16 <0.0001
Table 2. Fatty acid contents (mg/100 g) of longissimus dorsi muscle tissue in lambs fed various dietary PUFA 
enriched pellets. *Values within the same row bearing different superscripts differ (P < 0.05). Total FA is the 
combined FA contents. All other abbreviations are as defined in Table 1.
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level of less than 4.026. The DPA content is not currently considered as an omega-3 content claim under current 
regulations27; however, Australia and New Zealand have guidelines for total EPA + DHA + DPA consumption28. 
Byelashov, et al.29 revealed that DPA was related to various improvements in human health and served as a storage 
depot for EPA and DHA in the human body. Howe, et al.27 suggested that the importance of DPA in delivering the 
health benefits associated with n-3 LC-PUFA was equal to that of EPA and DHA. Therefore, if DPA was consid-
ered as an omega-3 content claim, a significant amount of n-3 LC-PUFA intake (~39%) would be added to lamb 
meat consumers as demonstrated in Fig. 1.
Edible by-products (organ meats) from cattle, pigs and lambs range from 20 to 30% of the animal’s live-
weight30. The findings of Bester et al.31 showed that lamb organ meats are nutrient-dense animal source foods that 
provide protein, zinc and iron to meet the nutritional requirements of humans. Furthermore, the edible internal 
organs of prime lambs (heart, liver and kidney) are rich in essential fatty acids32. Edible internal organs are widely 
consumed in many countries as special ingredients in traditional foods such as kidney pie in the United Kingdom, 
cooked and diced delicacies in South America, sheep liver in Iran and paté in many countries33. Therefore, knowl-
edge of the fatty acid profiles of lamb edible internal organs could contribute innovations in value-addition of 
edible meat by-products and generate extra income for lamb producers and slaughterhouses.
The liver is the first organ to receive and metabolise fatty acids after lipid digestion and absorption. As with 
previously reported studies11,32, individual fatty acid content was markedly high in the liver. Our observation of 
the lowest SFA and 18:0 contents in RPO treatment is supported by the work of Gallardo et al.34 who found that 
supplementation of ewes with 3% Ca soap FA in fish oil based diets dramatically reduced 18:0 content in milk. 
Shingfield et al.35 also observed that increased fish oil percentage in the diet linearly decreased 18:0 contents in 
the duodenum. The highest MUFA in CO (mainly 18:1n-9 contents) can be explained by the high MUFA (45.7%) 
input of CO into the diet. Similarly, the high LA and ALA contents (128.1 mg/100 g) in the liver of FSO fed lambs 
indicates that despite rumen biohydrogenation, a significant amount of ALA had escaped and was absorbed in the 
Fatty acid Control RBO CO FSO SO RPO SEM P
14:0 10.0a 10.0a 10.2a 8.5ab 7.7ab 4.7b 1.43 0.043
15:0 12.0a 7.3bc 9.0b 6.9bc 6.4bc 5.6c 0.86 0.000
16:1n-9c 10.5ab 11.1ab 12.9a 8.0bc 9.2ab 4.9c 1.31 0.004
16:1n-7c 20.4a 18.1ab 17.9ab 11.7c 12.8bc 13.4bc 1.94 0.017
16:0 526.9a 520.5a 541.8a 446.9ab 453.0ab 396.0b 35.51 0.044
17:0 56.9a 39.2b 44.7b 42.6b 41.5b 42.9b 2.61 0.001
18:2n-6 LA 209.5b 407.0a 389.3a 411.1a 434.5a 227.4b 30.30 <0.0001
18:3n-3 ALA 61.6c 70.2bc 104.3ab 128.1a 72.5bc 48.5c 11.83 0.000
18:1n-9 566.8ab 585.4ab 668.0a 423.6cd 459.1bc 313.1d 46.77 0.000
18:1n-7c 36.8b 48.1ab 52.4ab 41.3b 93.5a 64.3ab 15.95 0.041
18:1n-7t 57.1b 118.8ab 147.8a 172.9a 115.0ab 146.5a 22.77 0.023
18:0 748.8a 718.2a 792.8a 743.0a 737.8a 595.5b 30.43 0.002
20:4n-6 ARA 153.0b 243.3a 234.7a 189.5b 253.3a 109.8c 13.62 <0.0001
20:5n-3 EPA 55.3c 53.5c 81.0b 85.1b 57.6c 125.0a 7.68 <0.0001
20:3n-6 26.2 22.7 24.0 27.4 30.8 25.5 2.53 0.303
20:4n-3 7.7 9.8 9.6 6.1 5.2 11.4 2.55 0.515
20:2n-6 3.0b 4.9a 5.9a 5.2a 6.0a 4.5ab 0.55 0.008
20:0 3.7ab 3.1b 5.2a 2.8b 3.2b 4.5ab 0.57 0.045
22:5n-6 DPA-6 5.4b 9.9a 8.7a 4.6b 7.4ab 4.7b 1.05 0.004
22:6n-3 DHA 124.6bc 108.7c 147.1b 152.5b 132.2bc 289.5a 12.19 <0.0001
22:5n-3 DPA-3 147.7ab 134.8b 161.9ab 169.6a 143.7ab 172.4a 9.52 0.050
22:0 6.1ab 5.2b 7.3a 6.1ab 6.0ab 5.9ab 0.55 0.032
23:0 21.2 16.4 19.4 18.5 16.6 18.1 1.67 0.355
24:0 12.6 11.0 13.9 12.2 12.0 13.0 1.20 0.642
Total FA 3093.0b 3373.0ab 3775.0a 3325.0ab 3296.0ab 2776.0b 188.40 0.024
∑SFA 1398.0a 1331.0a 1444.0a 1287.0a 1284.0a 1086.0b 63.30 0.008
∑MUFA 798.3bc 878.4ab 1018.9a 775.0bc 784.2bc 615.7c 66.48 0.007
∑PUFA 829.8b 1110.0a 1234.1a 1206.5a 1180.5a 1034.9a 64.34 0.001
∑n-3 LC-PUFA 335.3cd 306.7d 399.6bc 413.2b 338.7cd 598.2a 24.52 <0.0001
∑n-3 PUFA 396.9d 378.3d 503.9bc 542.9b 412.4cd 647.1a 32.47 <0.0001
∑n-6 PUFA 412.8b 716.4a 712.7a 653.6a 755.4a 382.5b 43.05 <0.0001
∑other FA 66.2a 53.5ab 70.8a 55.7ab 47.2ab 38.8b 7.49 0.045
n-6/n-3 1.0c 1.9a 1.4b 1.3bc 1.9a 0.6d 0.11 <0.0001
Table 3. Fatty acid contents (mg/100 g) of the liver. *Values within the same row bearing different superscripts 
differ (P < 0.05). All other abbreviations are as defined in Tables 1 and 2.
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intestines and metabolised in the liver. Demirel et al.23 reported that feeding linseed more than doubled the con-
centration of ALA in the liver compared to Megalac diet. Out of all the PUFA of plant oil origin in this study, only 
FSO treatment had an n-3 LC-PUFA content that was significantly higher than the control. This could be explained 
in part, by the high ALA content in FSO being converted to n-3 LC-PUFA. Our result was in line with the findings 
of Alhazzaa et al.36 who reported that the gradual increase in ALA concentration led to a proportional increase 
in EPA in hepatocytes. The liver EPA and DHA contents of PUFA fed lambs ranged from 162.2 to 414.0 mg/100 g 
which was similar to EPA and DHA contents of wild Australian seafoods such as fish (containing 350 mg/150 g 
(~233 mg/100 g), shellfish (containing 225 mg/150 g (~150 mg/100 g) (see the review by Nichols et al.37). 
Furthermore, the n-6/n-3 ratio in the liver is within desirable level26. Therefore, the n-3 LC-PUFA content in the 
liver of PUFA fed lambs can be labelled as reaching the claimable ‘good source’ based on EPA + DHA threshold 
of the Food Standards of Australia and New Zealand guidelines25. Therefore, if lamb consumers consider the liver 
as their dietary protein source, they would obtain the associated dietary health benefits. In the heart, Kashani 
et al.38 reported that supplementation of lambs with Spirulina at the medium-level increased both n-3 and n-6 
PUFA compositions. The results from our study showed that total PUFA, n-3 LC-PUFA and n-6 PUFA contents 
of heart were all enhanced by supplementation with various PUFA enriched pellets. Furthermore, n-3 LC-PUFA 
contents in the heart of supplemented lambs ranged from 70.1 to 147.5 mg/100 g; indicating that the heart could 
be a ‘good source’ of n-3 LC-PUFA25. However, the n-6/n-3 ratio of the heart in all lambs with the exception of 
RPO, was much higher than the minimum desirable level of 4.026. The kidney samples in the present study had 
high contents of key health-benefitting n-3 LC-PUFA in agreement with the findings of Malau-Aduli et al.32. 
Specifically, our current findings showed that the contents of n-3 LC-PUFA ranged from 121.4 to 300.4 mg/100 g 
which is equal to the n-3 LC-PUFA content in Australian wild fish or shellfish (see details in the review by Nichols 
et al.37). The result of the present study demonstrated that supplementation of lambs with PUFA enriched pellets 
Fatty acid Control RBO CO FSO SO RPO SEM P
14:0 8.5 6.6 9.2 9.6 9.7 9.5 2.54 0.949
15:0 4.3 2.8 3.5 3.7 3.7 3.9 0.50 0.444
16:1n-9c 2.8 2.3 3.4 2.6 2.5 2.4 0.40 0.507
16:1n-7c 5.9ab 4.4b 5.6ab 5.3ab 4.9ab 7.7a 0.93 0.042
16:0 206.9 214.4 234.5 225.7 228.2 221.9 22.60 0.962
17:0 21.8a 14.5b 16.6ab 17.7ab 17.9ab 18.5ab 2.16 0.043
18:2n-6 LA 267.2c 489.2a 427.9ab 439.0ab 467.5a 365.9b 25.02 <0.0001
18:3n-3 ALA 23.2c 29.9bc 38.4b 51.3a 24.6c 27.5bc 3.73 <0.0001
18:1n-9 245.6 202.6 265.2 229.7 223.8 217.8 32.90 0.812
18:1n-7c 34.3b 38.8b 52.8a 37.3b 41.8ab 51.5a 4.03 0.011
18:1n-7t 21.0c 42.6b 44.3b 66.1a 53.2ab 51.6ab 6.42 0.001
18:0 309.0 312.2 327.2 332.8 342.1 271.5 35.17 0.769
20:4n-6 ARA 81.8b 128.6a 126.5a 101.7ab 135.0a 81.1b 10.82 0.002
20:5n-3 EPA 17.2d 25.0bcd 33.1bc 37.0b 21.2cd 65.6a 3.98 <0.0001
20:3n-6 9.6b 9.5b 9.9b 8.8bc 6.7c 12.5a 0.84 0.002
20:4n-3 2.4bc 1.3c 1.7c 1.5c 4.3ab 5.2a 0.78 0.004
20:2n-6 1.3c 1.9bc 2.2ab 1.9bc 2.5ab 2.7a 0.23 0.003
20:0 4.3 3.7 4.3 3.7 4.1 3.5 0.35 0.452
22:5n-6 DPA-6 1.0b 1.6a 1.3ab 1.0b 1.6a 1.5ab 0.17 0.042
22:6n-3 DHA 10.1c 14.8bc 17.2b 17.9b 15.8bc 39.8a 2.17 <0.0001
22:5n-3 DPA-3 25.3c 29.1bc 32.4abc 34.3ab 28.9bc 36.8a 2.39 0.024
22:0 6.0 6.1 5.8 5.4 5.8 5.2 0.31 0.336
23:0 11.6a 9.7b 9.0bc 9.3b 7.4c 8.9bc 0.59 0.001
24:0 6.4ab 6.7a 5.7ab 5.7ab 5.4b 5.9ab 0.39 0.045
Total FA 1611.0 1913.0 1992.0 1960.0 1961.0 1802.0 145.20 0.438
∑SFA 580.0 577.3 616.5 614.2 625.0 549.4 62.73 0.951
∑MUFA 360.8 344.0 431.7 406.1 384.0 386.8 46.16 0.803
∑PUFA 453.5b 745.7a 704.4a 705.4a 720.4a 646.4a 41.02 0.000
∑n-3 LC-PUFA 54.8c 70.2bc 84.4b 90.6b 70.1bc 147.5a 8.13 <0.0001
∑n-3 PUFA 78.2d 101.7cd 123.6bc 143.2b 95.7cd 175a 10.37 <0.0001
∑n-6 PUFA 363.9c 636.5a 572.6a 556.4ab 618.8a 467b 33.61 <0.0001
∑other FA 215.5 244.9 238.2 233.3 229.8 218.9 15.27 0.742
n-6/n-3 4.7b 6.3a 4.7b 4.1b 6.6a 2.7c 0.32 <0.0001
Table 4. Fatty acid contents (mg/100 g) of the heart. *Values within the same row bearing different superscripts 
differ (P < 0.05). All other abbreviations are as defined in Tables 1 and 2.
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substantially increased kidney n-3 LC-PUFA contents. Nguyen et al.11 also reported that supplementation of 
lambs with canola and flaxseed oils at 5% enhanced n-3 LC-PUFA contents of the kidney.
Conclusion
Supplementation of lambs with PUFA enhanced pellets in a feedlot system is needed to boost the contents of 
n-3 LC-PUFA in the longissimus dorsi muscle. Lambs in CO, FSO, SO and RPO treatments had contents of 
EPA + DHA in longissimus dorsi muscle that were over the claimable ‘source’ level of omega-3 as stipulated by 
the Foods Standards of Australia and New Zealand guidelines. Supplementation of lambs with oils of plant origin 
including canola, rice bran, flaxseed and safflower had similar effects on the contents of n-3 LC-PUFA in lamb 
longissimus dorsi muscle. FSO had the highest contents of ALA in the muscle, liver and heart tissues. Liver and 
kidney of PUFA fed lambs can be utilised as omega-3 rich foods on the basis of their high n-3 LC-PUFA contents 
and desirable n-3/n-6 ratios. In line with the tested hypothesis in this study, it is proven that canola, flaxseed, 
safflower and rumen protected oil infused pellets can be used in feedlot systems for producing healthy lamb 
meat as a source of omega-3 food. The cost-efficacy of supplementing lambs with these oil-infused pellets has 
been presented in detail in a separate stand-alone manuscript (currently under review) and details will not be 
duplicated herein. Suffice it to say that the feed cost per unit gain in Australian dollars/kg (AU$/kg) for RBO and 
CO supplements were 3.0 AU$/kg each, 4.1, 4.2 and 6.3 AU$/kg for RPO, FO and SO supplements, respectively.
Materials and Methods
This study was carried out at the Tasmanian Institute of Agriculture’s Cressy Research and Demonstration Station, 
Burlington Road, Cressy, Tasmania, Australia (41° 43′S, 147° 03′E) from April to June, 2016. The use of ani-
mals and procedures performed in this study were all approved by the University of Tasmania Animal Ethics 
Committee (Permit No A0015657).
Fatty acid Control RBO CO FSO SO RPO SEM P
14:0 3.7a 3.3ab 3.7a 2.2b 3.0ab 3.2ab 0.42 0.046
15:0 4.9a 2.8b 3.9ab 3.4b 4.0ab 3.6b 0.40 0.018
16:1n-9c 3.1b 2.7bc 4.1a 2.0c 2.9bc 2.2bc 0.31 0.001
16:1n-7c 5.8a 3.8bc 5.0ab 3.2c 3.8bc 5.3a 0.42 0.001
16:0 270.1 285.3 309.1 264.5 341.0 276.6 25.50 0.293
17:0 24.0a 18.2b 19.7ab 18.8b 22.3ab 19.7ab 1.54 0.041
18:2n-6 LA 167.0c 282.0b 272.3b 293.6b 375.8a 238.4b 23.95 <0.0001
18:3n-3 ALA 24.6a 16.8b 27.7a 30.0a 18.2b 16.3b 1.85 <0.0001
18:1n-9 238.8a 198.1ab 244.2a 165.6b 215.2ab 159.6b 17.83 0.006
18:1n-7c 25.5ab 27.6ab 34.5ab 23.6b 35.6a 30.7ab 3.47 0.043
18:1n-7t 13.8c 26.8bc 30.4ab 45.1a 43.0ab 39.0ab 5.35 0.002
18:0 305.9b 319.5ab 349.1ab 331.8ab 399.1a 300.6b 28.37 0.038
20:4n-6 ARA 132.4c 255.1b 247.5b 208.6bc 334.7a 136.2c 27.11 <0.0001
20:5n-3 EPA 54.0bc 34.5c 59.9bc 71.0b 45.2bc 139.3a 11.20 <0.0001
20:3n-6 10.8 11.7 12.3 17.9 16.6 16.6 2.46 0.214
20:4n-3 7.7 5.1 3.0 2.6 4.5 4.8 1.86 0.467
20:2n-6 3.4d 8.8ab 6.2c 7.5bc 10.9a 5.5cd 0.78 <0.0001
20:0 6.5b 6.3b 6.5b 6.0b 8.1a 5.0b 0.52 0.011
22:5n-6 DPA-6 0.3d 2.6a 1.6b 0.7cd 2.5a 1.1bc 0.19 <0.0001
22:6n-3 DHA 27.7c 42.8bc 52.2b 51.2b 56.8b 97.3a 6.59 <0.0001
22:5n-3 DPA-3 32.2c 51.7b 63.9ab 70a 64.5ab 59ab 5.14 0.000
22:0 31.0b 35.4ab 36.3ab 34.4b 44.0a 29.8b 2.89 0.025
23:0 13.4 10.7 11.0 11.0 12.7 11.3 0.85 0.158
24:0 38.9ab 38.7ab 40.3ab 36.9ab 46.7a 35.5b 3.13 0.032
Total FA 1611.0b 1855.0ab 2015.0ab 1857.0ab 2305.0a 1772.0b 160.60 0.038
∑SFA 699.4 720.9 780.4 709.9 882.1 686.2 61.24 0.232
∑MUFA 358.8ab 330.7ab 400.9a 315.2ab 383.4ab 301.1b 28.89 0.031
∑PUFA 475.5c 730.7b 765.2ab 764.6ab 951.7a 721.8b 66.99 0.002
∑n-3 LC-PUFA 121.4c 134.0bc 179.1bc 194.7b 171.0bc 300.4a 20.81 <0.0001
∑n-3 PUFA 146.1c 150.8c 206.8bc 224.6b 189.2bc 316.8a 21.66 <0.0001
∑n-6 PUFA 317.7d 571.2b 548.5bc 533.8bc 752.6a 401.3cd 51.39 <0.0001
∑other FA 76.9ab 72.0ab 68.3ab 66.7ab 87.7a 62.7b 6.62 0.041
n-6/n-3 2.2c 3.8a 2.7b 2.4bc 4.0a 1.3d 0.17 <0.0001
Table 5. Fatty acid contents (mg/100 g) of the kidney. *Values within the same row bearing different 
superscripts differ (P < 0.05). All other abbreviations are as defined in Tables 1 and 2.
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Animals, diets and experimental design. Seventy-two White Suffolk x Corriedale first-cross prime 
lambs with an average liveweight (LWT) of 35.7 ± 0.9 kg weaned at 6 months were randomly allocated into six 
treatments: (1) Control: lucerne hay only; wheat-based pellet infused with 50 ml/kg dry matter (DM) of oil from 
(2) rice bran (RBO); (3) canola (CO); (4) rumen-protected (RPO), (5) flaxseed (FSO) and (6) safflower (SO) 
sources in a completely randomized design balanced by equal number of ewe and wether lambs. The animals were 
kept in individual pens and had ad libitum access to clean fresh water and lucerne hay throughout the duration 
of the feeding trial. The lambs were sheltered in a roofed experimental shed with adequate ventilation and indi-
vidual lamb pen dimension was 6 m2 (1.2 m in width and 5 m in length). The average minimum and maximum 
temperatures during the experimental period were 6.5 °C and 19.7 °C in April and 3.4 °C and 12.6 °C in June, 
respectively. Average rainfall figures during the experimental period were 21.4 mm and 147 mm in April and June, 
respectively. Each lamb in the supplemented treatments was fed 1 kg pellets/day. The feeding trial lasted 10 weeks 
including a 3-week adaptation period and followed by 7 weeks of full supplementation. Freshly offered feed was 
given every day at 9.00 h after residual feed had been collected and weighed. The level of refusal of the concentrate 
supplement ranged from 0.14–0.18 kg DM/head/day. The chemical composition of the experimental and basal 
diets is presented in Table 6.
Procedures of feed sample and chemical composition determination. Every week, feed samples 
were taken from each pellet bag and bale of lucerne hay and bulked. The bulked samples were stored at −20 °C 
Figure 1. EPA + DHA and EPA + DHA + DPA contents per standard serve (135 g) in the longissimus dorsi 
muscle of prime lambs supplemented with diverse dietary PUFA sources (EPA: eicosapentaenoic acid; DPA: 
docosapentaenoic acid and DHA: docosahexaenoic acid; RBO, CO, RPO, FSO and SO were wheat-based pellets 
infused with 50 ml/kg DM of oil from rice bran, canola, rumen-protected, flaxseed and safflower sources, 
respectively).
Chemical 
composition (% DM) Lucerne hay RBO CO FSO SO RPO
DM 86.8 89.9 91.0 90.7 89.9 89.7
Protein 17.1 14.8 14.0 14.6 14.5 15.6
ADF 36.9 7.5 9.4 10.4 10.0 8.2
NDF 47.2 19.0 19.1 22.2 21.1 20.4
EE 1.5 5.5 5.6 5.6 5.5 5.1
ASH 8.4 6.7 6.2 8.2 8.2 6.5
%TDN 60.2 83.1 81.6 80.8 81.1 82.5
DE (Mcal/kg) 2.65 3.65 3.59 3.56 3.57 3.63
ME (MJ/kg) 9.08 12.54 12.32 12.20 12.25 12.46
Table 6. Proximate analysis of the experimental and basal diets. Dry matter (DM), Neutral detergent fibre 
(NDF), Acid detergent fibre (ADF), Ether extract (EE) and crude protein (CP), Total digestible nutrients 
(%TDN), Metabolisable energy (ME). Total digestible nutrients (%TDN) were calculated as TDN (% of 
DM) = 82.38 − (0.7515 × ADF [% of DM]). Metabolisable energy (ME) was calculated by converting 
%TDN to digestible energy (DE [Mcal/kg] = %TDN × 0.01 × 4.4) which was converted as ME = (DE (Mcal/
kg) × 0.82) × 4.185. All other abbreviations are as defined in Table 1.
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until the end of the feeding trial. The feed samples were dried at 60 °C over 72 h, ground to pass through a 1 mm 
sieve using a Laboratory Mill (Thomas Model 4 Wiley® Mill; Thomas Scientific) and analysed using the standard 
laboratory analytical methods of AOAC39 for DM and ash. Neutral Detergent (NDF) and Acid Detergent (ADF) 
fibre contents were determined using an Ankom Fibre Analyzer (ANKOM2000; ANKOM Technology, USA). 
Nitrogen content was quantified using a Thermo Finnigan EA 1112 Series Flash Elemental Analyzer and the val-
ues multiplied by 6.25 to give the estimated crude protein (CP) percentage. Ether extract (EE) was analysed using 
an ANKOMXT15 fat/oil extractor (ANKOM Technology, USA).
Slaughter protocol and fatty acid analysis. All animals were fasted overnight before transporting them 
to a near-by commercial abattoir (Tasmanian Quality Meats, Cressy, Tasmania) adjacent to the experimental site 
in strict compliance with the slaughter procedures prescribed by the Meat Standards of Australia guidelines40. 
Heart, kidney and liver samples were taken immediately after evisceration. All samples were vacuum-sealed, 
code-labelled and stored at −20 °C until fatty acid analysis. Thereafter, the carcasses were chilled for 24 h at 4 °C 
and longissimus dorsi muscle sampled at the 12/13th rib of each carcass as a commercial loin chop (approximately 
200 g) for FA analysis.
FA analyses of meat, organs and feed samples were conducted at the Commonwealth Scientific and Industrial 
Research Organization (CSIRO) Food Nutrition & Bio-based Products, Oceans & Atmosphere Laboratory in 
Hobart, Tasmania, Australia. The procedure of FA analysis was described in detail previously by Malau-Aduli, 
et al.32. In short, total lipids in 1 gram of un-homogenised and wet liver, kidney, heart and muscle tissue and 
feed samples were extracted overnight using a modified Bligh and Dyer41. The first step of the process was a 
single-phase overnight extraction using CHCl3:MeOH:H2O (1:2:0.8 v/v). The second step involved phase sepa-
ration with the addition of CHCl3:saline Milli-Q H2O (1:1 v/v) and followed by rotary evaporation of the lower 
chloroform phase at 40 °C to obtain total lipids. An aliquot from each total lipid extract was used in transmethyl-
ation process with MeOH:CHCl3:HCl (10:1:1 v/v) for 2 h at 80 °C and then fatty acid methyl esters (FAME) were 
extracted three times using hexane:CHCl3 (4:1 v/v). A known concentration of an internal standard (19:0) was 
added in 1500 µL vial containing the extracted FAME. The FAME was analysed on a 7890B gas chromatograph 
(Agilent Technologies, Palo Alto, CA, USA) equipped with an EquityTM-1 fused 15 m silica capillary column with 
0.1 mm internal diameter and 0.1-μm film thickness (Supelco, Bellefonte, PA, USA), a flame ionisation detector, 
a split/splitless injector and an Agilent Technologies 7683 B Series autosampler. The gas chromatograph condi-
tions were: splitless mode injection; carrier gas He; initial oven temperature 120 °C and then increased to 270 °C 
at 10 °C/min and to 310 °C at 5 °C/min. The Agilent Technologies ChemStation software (Palo Alto, California 
USA) was used to quantify fatty acid peaks. The fatty acid identities were confirmed by gas chromatograph-mass 
spectrometric (GC/MS) analysis using a Finnigan Thermoquest GCQ GC/MS fitted with an on-column injector 
and Thermoquest Xcalibur software (Austin, Texas USA). The gas chromatograph (GC) was equipped with an 
HP-5 cross-linked methyl silicone-fused silica capillary column (50 m × 0.32 mm internal diameter) which was 
of similar polarity to the column described above. The carrier gas was helium and GC conditions were according 
to the description of Miller, et al.42. FA percentages were computed as follows: FA% = (individual fatty acid area) 
∗ (100)/(sum total area of fatty acids). FA contents were calculated as follows: FA mg/100 g = (Total lipid) ∗ (LCF 
[0.916]) ∗ ([%FA]/100) ∗ 100043, where 0.916 was the lipid conversion factor cited by Clayton44.
Statistical analysis. Fatty acid data were initially transformed into fatty acid contents (mg/ 100 g). These 
data were then analysed using the General Linear Model procedure (PROC GLM) of Statistical Analysis System45. 
The fixed effects of treatment and gender and their second order interaction effects on fatty acid contents were 
tested. The initial full statistical model used for the analysis was: Y = μ + Oi + Gj + (OG)ij + (OG)2ij + (OG)3ij + 
eijk where Y = dependent variable, μ = overall mean, Oi = oil supplementation treatment, Gj = gender, brackets 
and superscripts represent linear and cubic second-order interactions and eijk = residual error. Linear and cubic 
orthogonal contrasts indicated that gender was not a significant factor, hence it was removed from the final model 
that assessed the impact of treatment only. Duncan’s multiple range tests were used to determine the differences 
amongst treatments at a minimum threshold of p < 0.05 level.
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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